🇨🇦 DNN.22.17.036 in Canada

DNN.22.17.036 (DNN.22.17.036) regulatory status in Canada.

Marketing authorisation

DNN.22.17.036 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Canada

Frequently asked questions

Is DNN.22.17.036 approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for DNN.22.17.036 in Canada?

Ache Laboratorios Farmaceuticos S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.